Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response

Agirre, X., Fontalba, A., Andreu, E.J., Odero, M.D., Larráyoz, M.J., Montiel, C. ORCID: 0000-0002-9144-8809, Calasanz, M.J., Fernández-Luna, J.L. and Prósper, F., 2003. Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response. Haematologica, 88 (12), pp. 1425-1426. ISSN 0390-6078

Full text not available from this repository.
Item Type: Journal article
Description: Letter to the editor
Publication Title: Haematologica
Creators: Agirre, X., Fontalba, A., Andreu, E.J., Odero, M.D., Larráyoz, M.J., Montiel, C., Calasanz, M.J., Fernández-Luna, J.L. and Prósper, F.
Publisher: Ferrata Storti Foundation
Date: 2003
Volume: 88
Number: 12
ISSN: 0390-6078
Identifiers:
NumberType
1265382Other
Divisions: Schools > School of Science and Technology
Record created by: Linda Sullivan
Date Added: 15 Jul 2021 16:04
Last Modified: 16 Jul 2021 07:45
Related URLs:
URI: http://irep.ntu.ac.uk/id/eprint/43494

Actions (login required)

Edit View Edit View

Views

Views per month over past year

Downloads

Downloads per month over past year